Peptide Price Finder

Home · Clinical trials

GHK-Cu clinical trials

ClinicalTrials.gov lists 1 registered trial of GHK-Cu: 1 recruiting or about to, 0 running, 0 completed. Recruiting sites are in China. The largest is Topical GHK-Cu Gel for Acute Skin Wound Healing (60 people).

1registered trials

1recruiting now

0running

0completed

0in phase 3

0with results posted

Recruiting: 11trials
  • Recruiting 1

Where GHK-Cu is in testing

Registered trials by phase. Phase 3 trials are the large ones that decide approval.

0Early phase 1First doses in people
0Phase 1Safety and dosing
1Phase 2Does it work?
0Phase 3Large confirmatory trials
0Phase 4After approval
0Not phasedObservational and other

Timeline

Each bar runs from a trial's start to its planned end; faded bars have no end date. Click a bar to open the trial.

202620272028Topical GHK-Cu Gel for Acute Skin Wound Healing · Recruiting · Phase 2 · 60 people · 2026-02-02 to 2027-02-14
RecruitingRunningCompletedStopped or withdrawnStatus unknownToday

Where trials are recruiting

Countries with sites in trials that are recruiting now.

Recruiting now 1

Topical GHK-Cu Gel for Acute Skin Wound Healing

RecruitingPhase 260 peopleRandomizedHudson Biotech2026-02-02 → 2027-02-14🇨🇳 China

Studying: Acute Standardized Cutaneous Wounds (Punch-biopsy Wounds) · NCT07437586

About this trial

This study will evaluate whether a topical gel containing GHK-Cu (a copper(II)-peptide complex) can safely speed up healing of small, standardized skin wounds in healthy adults compared with a matching vehicle gel. Participants will receive two small punch-biopsy wounds on the upper arm; each wound will be randomly assigned to receive GHK-Cu gel or vehicle gel under identical dressings. Wounds will be photographed and assessed over 3 weeks, with a follow-up visit to evaluate scar quality.

Registered trials include ones that haven't published results yet. Trials are matched on the compound's name and code names (GHK-Cu, copper peptide, GHK copper) in the listed interventions.